GlassScriptPhysician profile
Adil Iqbal
NPI 1255732905
$446.37
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $128 · 2022: $56.84 · 2024: $26.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $71.83 | 2019-2020 | |
| Lilly USA, LLC | $57.68 | 2019-2020 | |
| Ucb, INC. | $47.90 | 2019-2020 | |
| Medtronic, INC. | $43.13 | 2022 | |
| Arbor Pharmaceuticals, INC. | $31.47 | 2019 | |
| Biogen, INC. | $27.60 | 2019-2020 | |
| Penumbra, INC. | $26.49 | 2024 | Indigo System |
| Grifols USA, LLC | $23.57 | 2020 | |
| Genzyme Corporation | $21.64 | 2019 | |
| Amneal Pharmaceuticals LLC | $20.00 | 2019 | |
| Acorda Therapeutics, INC | $18.55 | 2019 | |
| Csl Behring | $15.79 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.74 | 2019 | |
| Abbvie INC. | $13.71 | 2022 | |
| Portola Pharmaceuticals, LLC | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.